Skip to main content
OpenTrials

Clinical trial condition

Lung Diseases, Obstructive

Explore clinical trials studying Lung Diseases, Obstructive. Study availability and eligibility vary by location and protocol.

7,975 public trials 742 recruiting studies
Refine in advanced search Browse all conditions

Lung Diseases, Obstructive trial results

Completed

Efficacy and Safety of the Addition of Fluticasone Propionate/Salmeterol (250/50mcg) Twice-daily to 2 Doses of Umeclidinium Bromide Inhalation Powder (62.5 or 125mcg) Once-daily Over 12 Weeks.

NCT01772147

Conditions
Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations
  • GSK Investigational Site Mobile, Alabama, United States
  • GSK Investigational Site Phoenix, Arizona, United States
  • GSK Investigational Site Huntington Beach, California, United States
  • GSK Investigational Site DeLand, Florida, United States
View all 55 locations
View Trial Details
Completed

Biomarker-based Cockroach Sublingual Immunotherapy Study (BioCSI)

NCT00829985

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +12 more
Locations
  • National Jewish Center Denver, Colorado, United States
  • Childrens Memorial Hospital Chicago, Illinois, United States
  • Johns Hopkins University School of Medicine Baltimore, Maryland, United States
  • Boston University School of Medicine Boston, Massachusetts, United States
View Trial Details
Completed

Inner-City Anti-IgE Therapy for Asthma

NCT00377572

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • University of Arizona Health Sciences Center Tucson, Arizona, United States
  • National Jewish Medical and Research Center Denver, Colorado, United States
  • Children's National Medical Center Washington D.C., District of Columbia, United States
  • Children's Memorial Hospital Chicago, Illinois, United States
View Trial Details
Completed

A Study to Assess the Effect of QAW039 in Non-atopic Asthmatic Patients

NCT01836471

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • Novartis Investigative Site Encinitas, California, United States
  • Novartis Investigative Site Huntington Beach, California, United States
  • Novartis Investigative Site Los Angeles, California, United States
  • Novartis Investigative Site Los Angeles, California, United States
View all 76 locations
View Trial Details
Completed

Extension Study to Evaluate the Safety and Efficacy of PT003, PT001, and PT005 in Subjects With Moderate to Very Severe COPD, With Spiriva® Handihaler® (PINNACLE 3)

NCT01970878

Conditions
Chronic Disease, Chronic Obstructive Pulmonary Disease (COPD), Disease Attributes, +6 more
Locations
  • Pearl Investigative Site Andalusia, Alabama, United States
  • Pearl Investigative Site Anniston, Alabama, United States
  • Pearl Investigative Site Athens, Alabama, United States
  • Pearl Investigative Site Birmingham, Alabama, United States
View all 125 locations
View Trial Details

Related conditions